Does ‘Free-Market Economy’ Work For Branded Generic Drugs In India?

On April 20, 2015, a panel of 31 lawmakers of the Standing Committee on Chemicals and Fertilizers tabled its report in the Indian Parliament. The committee emphasized that patients in India should have access to all medicines, including life saving drugs, … Continue reading

Alarming Incidence of Cancer: Fragile Infrastructure: Escalating Drug Prices

According to the ‘Fact-Sheet 2014′ of the World Health Organization (WHO), cancer cases would rise from 14 million in 2012 to 22 million within the next two decades. It is, therefore, no wonder that cancers figured among the leading causes … Continue reading

Cheaper Drugs: Happy Patients: Angry Industry

Recent price reductions of a number of cardiovascular and diabetes drugs falling outside the National List of Essential Medicines 2011 (NLEM 2011), have attracted fury of the pharma industry . By a notification dated July 10, 2014, the National Pharmaceutical … Continue reading

The New Government To Ponder: Is “Market Based Drug Pricing Policy” An ill Conceived One?

According to a recent media report, Mr. Ananth Kumar, the new minister of Chemicals and Fertilizers has recently made a statement, as follows: “… As far as branded medicines of multinational pharmaceutical companies are concerned, we will talk to all … Continue reading

Are pharmaceuticals related more to chemicals than health?

I received a call from Professor Sam Gupta yesterday. (please refer to my article at: http://www.tapanray.in/profiles/blogs/the-professor-counterfeit) He is returning to the US next week. Before that, he felt, it will be nice if he and I can manage some time … Continue reading